MedTrace Logo

SmartTouch Catheter for Left Anterior Line - SmarT Line Study

NCT02217657 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2021-02-25

No results posted yet for this study

Summary

This prospective, randomized study will investigate, if information of the catheter force during ablation of a left anterior line does reduce total RF application time by prevention of ineffective lesions.

Conditions

  • Persistent Atrial Fibrillation

Interventions

DEVICE

Thermocool Smart Touch Catheter

Physician informed to contact force

Sponsors & Collaborators

  • LMU Klinikum

    lead OTHER

Principal Investigators

  • Heidi Estner, MD · Munich University Clinic, Campus Großhadern

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02217657 on ClinicalTrials.gov